A multi-institutional, phase II open-label study of...

Endocrine Related Cancer 2013 / 05 Vol. 20; Iss. 3

A multi-institutional, phase II open-label study of ganitumab (AMG 479) in advanced carcinoid and pancreatic neuroendocrine tumors

Strosberg, J. R., Chan, J. A., Ryan, D. P., Meyerhardt, J. A., Fuchs, C. S., Abrams, T., Regan, E., Brady, R., Weber, J., Campos, T., Kvols, L. K., Kulke, M. H.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Language:
english
Journal:
Endocrine Related Cancer
DOI:
10.1530/erc-12-0390
Date:
May, 2013
File:
PDF, 165 KB
english, 2013
Conversion to is in progress
Conversion to is failed